Avoro Capital Advisors reported a 9.64% stake in Arrowhead Pharmaceuticals ARWR · 13,823,383 sh · amendment · passive holder

Trade details

Type: 5% stake report
Report: 13G passive · amendment
Stake: 9.64%
Last report: 8.3% · filed 25/08/14
Shares held: 13,823,383 sh
Class: Common Stock, par value $0.001 per share
Stock: Arrowhead Pharmaceuticals ARWR
Holder: Avoro Capital Advisors
Event date: 26/06/30
Filed: 26/08/14

9.64% stake · +1.3pp from the last report

Stake: 9.64%
Last report: 8.3%
Since last report: +1.3pp

Arrowhead Pharmaceuticals trades, last 26 weeks

What else happened in Arrowhead Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 05/31~07/30

Avoro Capital Advisors's other 5% stake reports

Avoro Capital Advisors
5% stakeHemab Therapeutics Holdings
5% stake
Hemab Therapeutics Holdings
COAG
7.06% stake
3,298,236 sh
7.06% stake
Filed 08/14
Avoro Capital Advisors
5% stakeAvalo Therapeutics
5% stake
Avalo Therapeutics
AVTX
4.44% stake
2,333,333 sh
4.44% stake
Filed 08/14
Avoro Capital Advisors
5% stakeScribe Therapeutics
5% stake
Scribe Therapeutics
SCTX
16.37% stake
3,088,888 sh
16.37% stake
Filed 07/30
Avoro Capital Advisors
5% stakeDamora Therapeutics
5% stake
Damora Therapeutics
DMRA
6.27% stake
3,783,000 sh
6.27% stake
Filed 05/15
Avoro Capital Advisors
5% stakeAvalo Therapeutics
5% stake
Avalo Therapeutics
AVTX
5.75% stake
1,410,000 sh
5.75% stake
Filed 05/15